AMGN
Amgen Inc
406.00$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.3% | -4.3% | -2.2% | 0.0% | +1.1% | -2.7% | -1.6% | +2.6% | +0.5% | +2.1% | +3.4% | |
| – | -37.4% | -7.6% | -2.9% | -1.6% | +8.5% | -7.2% | -0.7% | +4.3% | +4.2% | +8.3% | +11.1% | |
| – | -68.5% | -11.3% | -4.2% | -3.1% | +32.9% | -26.4% | -8.9% | +17.7% | -3.3% | +31.9% | +16.2% | |
| – | -68.5% | -11.3% | -4.2% | -3.1% | +32.9% | -26.4% | -8.9% | +17.7% | -3.3% | +31.9% | +16.2% | |
| – | +29.2% | -14.7% | +2.3% | +5.5% | +2.5% | +8.4% | +7.0% | -2.4% | +12.7% | -4.5% | +11.9% | |
| – | +89.4% | -8.3% | -8.4% | -7.9% | -4.9% | -3.8% | -2.2% | -3.6% | -1.9% | -0.6% | +0.5% | |
| – | +20.1% | -0.3% | +0.2% | +0.2% | -0.1% | +0.0% | +0.2% | +0.0% | +0.0% | 0.0% | 0.0% | |
| – | +148.2% | -3.9% | -3.8% | -4.1% | -4.2% | -7.1% | -4.3% | -6.0% | -3.7% | -4.0% | -4.2% | |
| – | +9.7% | -3.3% | -3.4% | -1.9% | +3.1% | -3.3% | -3.2% | +0.1% | +1.7% | +1.7% | +0.8% | |
| – | +8.5% | +7.2% | +9.1% | -5.6% | +13.7% | -0.4% | -11.0% | +6.4% | +17.0% | -2.1% | +2.2% | |
| – | +1.1% | +174.4% | +39.6% | -35.9% | +0.2% | -5.1% | -27.4% | -11.9% | +113.6% | +18.2% | +0.1% | |
| – | +17.1% | +2.4% | +39.3% | -5.3% | -11.1% | +26.1% | +25.1% | -5.7% | -16.6% | +24.0% | +583.4% | |
| – | +7.0% | -4.9% | -4.9% | -0.5% | -0.5% | -4.5% | -0.5% | -2.5% | -4.6% | +3.8% | -0.1% | |
| – | -18.6% | -19.4% | +18.0% | +27.0% | -21.9% | +5.6% | +19.7% | +29.5% | -10.0% | +6.1% | +27.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | -0.7% | +0.9% | +0.2% | +0.0% | -0.2% | +0.0% | +0.2% | +0.2% | +0.2% | +0.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.